Alnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast

benzinga.com/markets/earnings/25/07/46772818/alnylam-pharmaceuticals-q2-earnings-crush-estimates-stock-hits-52-week-high-on-upbeat-forecast

The biotechnology sector is witnessing a surge in investor optimism as companies like Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) continue to outperform market expectations. Amid a backdrop of growing demand for innovative treatments, Alnylam’s recent performance highlights the company’s…

This story appeared on benzinga.com, 2025-07-31 19:36:36.
The Entire Business World on a Single Page. Free to Use →